These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 3106232

  • 1. [Experiences with a Pseudomonas immunoglobulin in artificially respirated patients with Pseudomonas pneumonia at a surgical intensive care unit].
    Böhm D.
    Infection; 1987; 15(1):73-5. PubMed ID: 3106232
    [Abstract] [Full Text] [Related]

  • 2. [Experiences with a Pseudomonas immunoglobulin in ventilated patients with Pseudomonas pneumonia in a surgical intensive care station].
    Böhm D.
    Infection; 1987; 15 Suppl 2():S64-6. PubMed ID: 3112023
    [Abstract] [Full Text] [Related]

  • 3. [Use of Pseudomonas immunoglobulin in artificially respirated patients at an interdisciplinary surgical intensive care unit].
    Class I, Junginger W, Klöss T.
    Infection; 1987; 15(1):76-9. PubMed ID: 3106233
    [Abstract] [Full Text] [Related]

  • 4. [Use of pseudomonas immunoglobulin in ventilated patients at an interdisciplinary surgical intensive care station].
    Class I, Junginger W, Klöss T.
    Infection; 1987; 15 Suppl 2():S67-70. PubMed ID: 3112024
    [Abstract] [Full Text] [Related]

  • 5. [Use of pseudomonas immunoglobulin. Indications and results].
    Werdan K, Melnitzki S, Pilz G, Reuschel-Janetschek E.
    Anasth Intensivther Notfallmed; 1989 Jun; 24(3):153-61. PubMed ID: 2504071
    [Abstract] [Full Text] [Related]

  • 6. [Adjuvant therapy with pseudomonas immunoglobulin in artificially ventilated patients at a surgical intensive care unit].
    Class I, Schorer R.
    Anasth Intensivther Notfallmed; 1989 Jun; 24(3):167-71. PubMed ID: 2504072
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic strategies for Pseudomonas aeruginosa pneumonia in the myelosuppressed host.
    Pennington JE.
    Antibiot Chemother (1971); 1987 Jun; 39():51-9. PubMed ID: 3118791
    [No Abstract] [Full Text] [Related]

  • 8. Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.
    Pennington JE, Pier GB, Sadoff JC, Small GJ.
    Rev Infect Dis; 1986 Jun; 8 Suppl 4():S426-33. PubMed ID: 2944209
    [Abstract] [Full Text] [Related]

  • 9. Use of passive immunotherapy in the treatment of experimental Pseudomonas aeruginosa infections in burns.
    Neely AN, Holder IA.
    Antibiot Chemother (1971); 1987 Jun; 39():26-40. PubMed ID: 3118788
    [No Abstract] [Full Text] [Related]

  • 10. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE, Pier GB.
    Infection; 1987 Jun; 15(1):56-9. PubMed ID: 3106230
    [Abstract] [Full Text] [Related]

  • 11. [Pseudomonas aeruginosa immunoglobulin in experimental pneumonia].
    Pennington JE, Pier GB.
    Infection; 1987 Jun; 15 Suppl 2():S47-50. PubMed ID: 3112020
    [Abstract] [Full Text] [Related]

  • 12. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia.
    Rello J, Ausina V, Ricart M, Puzo C, Quintana E, Net A, Prats G.
    Intensive Care Med; 1994 Jun; 20(3):193-8. PubMed ID: 8014285
    [Abstract] [Full Text] [Related]

  • 13. A clinical trial of i.v. tetravalent hyperimmune Pseudomonas globulin G in burned patients.
    Hunt JL, Purdue GF.
    J Trauma; 1988 Feb; 28(2):146-51. PubMed ID: 3126302
    [Abstract] [Full Text] [Related]

  • 14. [Prevention using a Pseudomonas immunoglobulin in burn patients].
    Stuttmann R, Petrovici V, Hartert M.
    Infection; 1987 Feb; 15(1):80-4. PubMed ID: 3106234
    [Abstract] [Full Text] [Related]

  • 15. Pulmonary clearance of Pseudomonas aeruginosa in neutropenic mice. Effects of systemic immunization.
    Dunn MM, Kamp DW.
    Am Rev Respir Dis; 1987 Jun; 135(6):1294-9. PubMed ID: 3109290
    [Abstract] [Full Text] [Related]

  • 16. Safety and pharmacokinetics of an anti-PcrV PEGylated monoclonal antibody fragment in mechanically ventilated patients colonized with Pseudomonas aeruginosa: a randomized,double-blind, placebo-controlled trial.
    François B, Luyt CE, Dugard A, Wolff M, Diehl JL, Jaber S, Forel JM, Garot D, Kipnis E, Mebazaa A, Misset B, Andremont A, Ploy MC, Jacobs A, Yarranton G, Pearce T, Fagon JY, Chastre J.
    Crit Care Med; 2012 Aug; 40(8):2320-6. PubMed ID: 22622405
    [Abstract] [Full Text] [Related]

  • 17. [Prevention of gram-negative and gram-positive infections using 3 intravenous immunoglobulin preparations and therapy of experimental polymicrobial burn infection using intravenous Pseudomonas immunoglobulin G and ciprofloxacin in an animal model].
    Collins MS, Hector RF, Roby RE, Edwards AA, Ladehoff DK, Dorsey JH.
    Infection; 1987 Aug; 15(1):60-8. PubMed ID: 3570485
    [Abstract] [Full Text] [Related]

  • 18. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A, Foucrier A, Dupont H, Montravers P, Ouattara A, Kalfon P, Squara P, Simon T, Amour J, iDIAPASON study group.
    Trials; 2017 Jan 23; 18(1):37. PubMed ID: 28114979
    [Abstract] [Full Text] [Related]

  • 19. Fulminant primary Pseudomonas aeruginosa pneumonia and septicaemia in previously well adults.
    Henderson A, Kelly W, Wright M.
    Intensive Care Med; 1992 Jan 23; 18(7):430-2. PubMed ID: 1469184
    [Abstract] [Full Text] [Related]

  • 20. Passive immune therapy for experimental Pseudomonas aeruginosa pneumonia in the neutropenic host.
    Pennington JE, Small GJ.
    J Infect Dis; 1987 May 23; 155(5):973-8. PubMed ID: 3104484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.